Boothbay Fund Management’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $457K | Hold |
224,130
| – | – | 0.01% | 758 |
|
|
2025
Q1 | $298K | Sell |
224,130
-36,146
| -14% | -$48.1K | 0.01% | 902 |
|
|
2024
Q4 | $690K | Buy |
260,276
+153,573
| +144% | +$407K | 0.02% | 636 |
|
|
2024
Q3 | $194K | Hold |
106,703
| – | – | ﹤0.01% | 1214 |
|
|
2024
Q2 | $177K | Hold |
106,703
| – | – | ﹤0.01% | 1149 |
|
|
2024
Q1 | $244K | Buy |
106,703
+10,958
| +11% | +$25.1K | ﹤0.01% | 1108 |
|
|
2023
Q4 | $190K | Hold |
95,745
| – | – | ﹤0.01% | 1185 |
|
|
2023
Q3 | $124K | Hold |
95,745
| – | – | ﹤0.01% | 1321 |
|
|
2023
Q2 | $155K | Hold |
95,745
| – | – | ﹤0.01% | 1317 |
|
|
2023
Q1 | $204K | Buy |
95,745
+5,460
| +6% | +$11.6K | ﹤0.01% | 1498 |
|
|
2022
Q4 | $334K | Buy |
+90,285
| New | +$334K | 0.01% | 1124 |
|
|
2021
Q4 | – | Sell |
-18,191
| Closed | -$152K | – | 1939 |
|
|
2021
Q3 | $152K | Sell |
18,191
-20,217
| -53% | -$169K | ﹤0.01% | 1425 |
|
|
2021
Q2 | $259K | Buy |
+38,408
| New | +$259K | 0.01% | 1214 |
|
|
2020
Q1 | – | Sell |
-36,051
| Closed | -$357K | – | 916 |
|
|
2019
Q4 | $357K | Buy |
+36,051
| New | +$357K | 0.03% | 486 |
|